A daily oral GLP-1 pill can help people with obesity lose about 12% of their body weight, according to early data shared by drugmaker Eli Lilly today. The medication, called orforglipron, may be a ...

Oramed Granted U.S. Combination Therapy Patent for Oral GLP-1 & Insulin for the Treatment of Diabetes ...

Learn more about the gut microbiome’s digestion of the amino acid tryptophan, which creates byproducts with potential for ...

DelveInsight’s, “Diabetes Pipeline Insight 2025” report provides comprehensive insights about 200+ companies and 200+ pipeline drugs in the Diabetes pipeline landscape. It covers the Diabetes pipeline ...

The combination of azemiglitazone and the GLP-1 liraglutide, new body composition measurements demonstrated a significantpreservation of lean body mass (or muscle) in the combined presence of ...

A GLP-1 in pill form from Eli Lilly shows promising results for weight loss and Type 2 diabetes treatment in a trial. FDA approval is expected in 2026.

More people are "microdosing" GLP-1 medications like Ozempic, Wegovy, and Mounjaro. Here's what to know and what to be cautious of, according to doctors.

This story mentions weight, weight loss, and/or prescription GLP-1 drugs, which are FDA-approved for weight management in adults diagnosed with obesity or with overweight and at least one weight ...

COYA 303 is an investigational biologic combination of COYA 301, Coya’s low-dose interleukin 2 (LD IL-2) and a GLP-1 receptor agonist (GLP-1RA), designed to deliver a multi-targeted ...